Pinnacle Wealth Management Advisory Group’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-12,445
Closed -$9.19K 374
2024
Q4
$9.19K Hold
12,445
﹤0.01% 356
2024
Q3
$19.5K Hold
12,445
﹤0.01% 359
2024
Q2
$20.9K Hold
12,445
﹤0.01% 349
2024
Q1
$29.9K Hold
12,445
﹤0.01% 346
2023
Q4
$19K Buy
12,445
+310
+3% +$369 ﹤0.01% 332
2023
Q3
$13.2K Hold
12,135
﹤0.01% 313
2023
Q2
$27.8K Buy
12,135
+750
+7% +$1.99K ﹤0.01% 325
2023
Q1
$27.7K Buy
11,385
+965
+9% +$2.21K ﹤0.01% 313
2022
Q4
$19.9K Buy
10,420
+280
+3% +$596 ﹤0.01% 296
2022
Q3
$24K Buy
+10,140
New +$28.1K ﹤0.01% 274

Other funds holding LXRX